跳至主要内容
临床试验/NCT00870038
NCT00870038Unknown4 期

Early Re-Endothelialization Might Not be the Unique Solution to Prevent Restenosis. The EREMUS Study

Ospedale della Misericordia2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2010年12月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
75
试验地点
2
主要终点
Late luminal loss between the three groups at 6 months angiographic follow up.

研究概览

简要总结

The investigators sought to discover which one of the following strategies is the safest for patients undergoing percutaneous coronary intervention: paclitaxel-coated balloon+Genous stent; Genous stent; drug eluting stent (paclitaxel).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable or unstable angina pectoris suitable to PCI of at least one coronary vessel
  • Age >18 years

排除标准

  • Recent (<72 hours) acute myocardial infarction
  • Creatinine clearance <40 ml/min
  • Allergy or hypersensitivity to at least two between: aspirin, clopidogrel, heparin, bivalirudin, paclitaxel, contrast media
  • Life expectancy <1 year

结局指标

主要结局

Late luminal loss between the three groups at 6 months angiographic follow up.

时间窗: 6 months

Percent of stent struts covered by endothelium at optical coherence tomography, during 6 months angiographic follow up.

时间窗: 6 months

次要结局

  • Angiographic restenosis (6 months angiographic follow up).(6 months)
  • Net adverse clinical events at 6 months (death, myocardial infarction, target lesion revascularization, bleedings as from Acuity scale).(6 months)

研究者

发起方
Ospedale della Misericordia
申办方类型
Other

研究点 (2)

Loading locations...

相似试验